Elabor, A., Molnar, E., King, M., & Gallagher, J. (2018). 2382. Ceftolozane/Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections in Immunocompromised Patients: A Multi-Center Study. Open Forum Infect Dis.
Citación estilo ChicagoElabor, Abdulrahman, Esther Molnar, Madeline King, and Jason Gallagher. "2382. Ceftolozane/Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas Aeruginosa Infections in Immunocompromised Patients: A Multi-Center Study." Open Forum Infect Dis 2018.
Cita MLAElabor, Abdulrahman, Esther Molnar, Madeline King, and Jason Gallagher. "2382. Ceftolozane/Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas Aeruginosa Infections in Immunocompromised Patients: A Multi-Center Study." Open Forum Infect Dis 2018.